SINCE ASCHOFF' first described in 1904 lesions in the heart which have subsequently become known as Aschoff bodies, these lesions have been sought at necropsy in patients with valvular heart disease. Of 518 necropsy patients with valvular heart disease reported from 1934 to 1961 (table 1), the percent with Aschoff bodies varied enormously (from 9 to 84% [avg 421).2 12 These 11 previous studies (table 1)2-12 were based on variable and often unclear criteria for defining Aschoff bodies. Because of this marked variation in reported frequency of Aschoff bodies in necropsy patients and because of a previous study by us on the frequency of Aschoff bodies in operatively excised atrial appendage and papillary muscle,13 it appeared worthwhile to examine a large number of necropsy patients with chronic valvular heart disease to determine the frequency and clinical significance of Aschoff bodies.
Patients Studied and Methods
All patients with chronic valvular heart disease in whom necropsy was performed at the Clinical Center of the National Institutues of Health and all necropsy patients with valvular heart disease in whom the heart was submitted to the Pathology Branch of the National Heart, Lung, and Blood Institute between 1953 and 1972 were included in this analysis. A total of 543 necropsy patients with severe (functional class III or IV, New York Heart Association classification) chronic valvular heart disease was analyzed (table 2). Each of the 543 hearts was examined grossly and histologically by one of us (WCR) and the cases were classified according to the functional valve lesion detected clinically (table 2) . Tricuspid regurgitation, however, was not included in the functional classification. In over 90% of the 543 patients, the functional valve lesions had been confirmed by, or diagnosed by, cardiac catheterization with or without angiography. In addition to classifying the patients mitral valve leaflets, and all but one had diffuse anatomic lesions of at least one other cardiac valve. No patient with anatomic lesions limited to the aortic valve had Aschoff bodies. Thus, among patients with chronic valvular heart disease, Aschoff bodies, the only anatomic lesion pathognomonic of rheumatic heart disease, indicate diffuse anatomic lesions of the mitral leaflets and usually also anatomic lesions of one or more other cardiac valves. The functional mitral lesion is usually stenosis. by their functional valve lesions, each was also classified anatomically. Some patients with clinically isolated mitral stenosis, for example, at necropsy also had diffuse anatomic lesions of the aortic valve. Therefore, these patients were classified anatomically as mitral plus aortic but clinically only as mitral stenosis (table 2) . Also, for a valve to be considered abnormal anatomically there must have been diffuse thickening of all portions of each valve cusp or thickening of the margins around the entire valve circumference ( fig. 1 ). Focal leaflet thickening, i.e., sparing at least some marginal areas, was not considered indicative of anatomic abnormality.
Of the 543 patients, their ages at death ranged from 15 to 88 years (avg 45); 64% were men and 36%, women. A cardiac operation (valve commissurotomy, anuloplasty or replacement) had been performed in 372 (69%) of the 543 patients.
At least one section of wall of each cardiac chamber was cut, processed, stained (hematoxylin-eosin) and examined histologically. Each section included the through-andthrough thickness of wall from endocardium to epicardium. Each section for histologic study was at least 2 cm in maximal dimension. At least four histologic sections were examined from each patient, an average of seven per patient. The criteria used for recognizing Aschoff bodies are those proposed by Saphir'4 and summarized in table 3.
Results
Aschoff bodies were found in the heart in 11 (2%) of the 543 patients (table 2). The frequency of the Aschoff bodies in these 11 patients were numerous in six, many in one, and rare in four. The patients with either numerous or many Aschoff bodies had these structures in the walls of at least three of the four cardiac chambers and multiple ones were observed in the sections. In contrast, the patients with rare Aschoff bodies had these structures in the walls of only one or two chambers: in two patients, only in left ventricle, and in the other two, both left ventricle and left atrium. In the four patients with rare Aschoff bodies, only three to six of these structures were observed per patient in all the sections examined. In two patients, Aschoff bodies also were observed in epicardium and each of these patients had numerous Aschoff bodies. In all 11 patients Aschoff bodies were observed in both mural endocardium and in myocardium. Aschoff bodies were not observed in valvular endocardium in any patient but sections of valve were not examined in all patients. The number of histologic sections of heart examined in each of the 1 1 patients with Aschoff bodies ranged from 6 to 16 (avg 10).
The functional and anatomic valvular lesions in the 11 patients with Aschoff bodies are summarized in table 4. Of the 11 patients, nine had mitral stenosis with or without functional lesions of other cardiac valves, one had pure aortic regurgitation and one had both aortic and mitral regurgitation. Although only 18 functional valve lesions (excluding tricuspid regurgitation) were observed in the 11 patients with Aschoff bodies, 26 anatomic valve lesions were present in these patients. All 11 patients had anatomic lesions of the mitral valve ( fig. 1 ), ten had anatomic involvement of the aortic valve, four also of the tricuspid valve, and one also of the pulmonic valve. Thus, of the 11 patients, only one had anatomic lesions limited to only one valve (mitral), and the other ten had anatomic lesions of two or more valves.
Certain clinical features in the 11 necropsy patients with Aschoff bodies are summarized in table 5 and these observations are compared to those in our previous study14 of 45 surgical patients with Aschoff bodies in operatively excised atrial appendage or papillary muscle.
Comments
The last reported study describing the frequency of Aschoff bodies at necropsy in patients with valvular heart disease appeared in 1961 and concerned only 24 patients. 12 The largest previous study on this subject appeared in 1934 and concerned 161 patients. 2 Although several studies on the frequency of Aschoff bodies at necropsy appeared between 1934 and 1961, none provided much clinical information regarding the patients with Aschoff bodies, few described the relative frequency of distribution of the Aschoff bodies in the heart, and none described the number(s) of cardiac valves involved anatomically or functionally other than mitral stenosis. In the present study a larger group of patients, 543, were examined than in all the previous studies combined. Furthermore, the types of functional and anatomic valvular lesions in our 543 patients were classified by reexamination of all 543 hearts by the same examiner and a relatively large number of histologic sections were examined from each heart. Despite this extensive search, the frequency of Aschoff Presumably, differences in histologic criteria used to diagnose Aschoff bodies explains some of the difference. Also, the more frequent use of penicillin in our patients also may have prevented repeated attacks of acute rheumatic fever."5 Although the ages of the reported necropsy patients were available in only two previous studies,6"2 it is likely that our patients were on the average older than those described in the previous reports (table 1) . Our study, for example, excluded patients under 15 years of age. The composition of our 543 patients, most of whom were studied at one institution, probably differed considerably from that of the previously reported 518 patients from multiple institutions. Almost surely the frequency of isolated aortic stenosis was greater in our study patients (182 of the 543) and none of them had Aschoff bodies at necropsy. Aschoff bodies, to our knowledge, have never been described in a patient with isolated aortic valve lesions. In contrast, of the 357 previously reported patients in whom the functional valve lesion was mentioned, 343 (96%) had mitral stenosis. Among our 543 patients, 206 had mitral stenosis, with or without a functional lesion involving other cardiac valves, and only 9 (4%) of them had Aschoff bodies. Thus, it is likely that the incidence of Aschoff bodies is dropping in patients with chronic valvular heart disease just as is the incidence of acute rheumatic fever itself. '5 Although the presence of Aschoff bodies nearly always indicates the presence of mitral stenosis (table 1), there are exceptions. Of our 11 patients with Aschoff bodies, nine had mitral stenosis but the other two had purely regurgitant lesionspurely aortic in one, and combined aortic and mitral in the other. Although mitral stenosis is not quite uni- . 1 ) of the mitral valve does appear to be universal among the patients with Aschoff bodies. Mitral stenosis, obviously, always indicates diffuse anatomic lesions of the mitral leaflets. In each of our two patients without mitral stenosis but with Aschoff bodies, both, nevertheless, had diffuse anatomic lesions of the mitral leaflets, in one causing no mitral valve dysfunction and in the second causing pure mitral regurgitation. Among the 45 surgical patients in whom Aschoff bodies were observed by us in either atrial appendage or papillary muscle or both, 44 had mitral stenosis, and the remaining one, a 10-year-old boy, had pure mitral regurgitation."4 Thus, all 45 had diffuse anatomic lesions of the mitral valve. Accordingly, we define rheumatic heart disease as a disease at least anatomically of the mitral valve ( fig. 1 ). Other valves also may be involved either anatomically or functionally or both, but always the mitral valve is involved anatomically, either diffusely or at their margins, and, with rare exception, the functional mitral lesion is stenosis, with or without regurgitation, and rarely, pure regurgitation. The frequency of Aschoff bodies in our 543 necropsy patients is significantly (P < 0.01) different from the frequency in our 481 surgical patients (previously described14) in whom the left atrial appendage or left ventricular papillary muscle or both were examined histologically. The frequency of Aschoff bodies in the necropsy patients was 2% and in the surgical patients, 9%. This comparison, however, has deficiencies because the necropsy patients include a large number, namely 182, with disease only of the aortic valve, whereas the surgical group excludes patients with aortic valve disease. Thus, among the 301 necropsy patients with only mitral valve disease, either stenosis or pure mitral regurgitation or both, with or without involvement of other cardiac valves, Aschoff bodies were found in 10 (3%); in contrast, among the 481 surgical patients with mitral valve disease, 45 (9%) had Aschoff bodies (P < 0.01).
Because Aschoff bodies are observed most frequently in patients with mitral stenosis, comparison of the necropsy and surgical patients with this particular lesion is more . 3 ). Aschoff bodies are significantly more frequent in patients with mitral stenosis than in patients with pure mitral regurgitation. Thus, of 95 necropsy patients examined who had pure mitral regurgitation, with or without dysfunction of one or more other cardiac valves, only one (1%) had Aschoff bodies (figs. 2 and 4), whereas of 206 necropsy patients with mitral stenosis, with or without dysfunction of one or more other cardiac valves, 9 (4%) had Aschoff bodies ( fig. 2 ).
Among our 11 patients with Aschoff bodies at necropsy, nine had good historical evidence in the past of acute rheumatic fever. Although we are aware that historical evidence always represents "soft" data, the frequency of a positive history of acute rheumatic fever is strikingly different between patients with mitral valve disease compared to those with aortic valve disease. Among our 192 patients with clinically isolated aortic stenosis (table 2), only 12% had a history compatible with acute rheumatic fever. In contrast, of our 206 patients with mitral stenosis, with or without dysfunction of one or more other cardiac valves, 72% had a positive history of acute rheumatic fever. Thus, in general, among patients with chronic valvular heart disease, a positive history of acute rheumatic fever indicates a diffuse anatomic lesion of the mitral valve. The anatomic lesion, however, may or may not be of functional significance.
